Medicinal product name Betaklav 400 mg/57 mg/5 ml powder for oral suspension
Pharmaceutical form Powder for oral suspension
Strength 400 mg/57 mg/5 ml 
Information from the MAH on shortages No information on expected shortages
Legal status Rx Prescription (Pr.)
KZSR Reimbursed medicines reference product
Package leafletPDF 01-02-2024
Summary of product characteristicsPDF 01-02-2024
ATC code J01CR02 Antibacterials for systemic use
Information for Marketing authorisation holdersView

Medicinal products (4)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1
(30 ml)
HDPE bottle    15-0236-01 Labelling text Labelling text Feb 1, 2024
Labelling text Labelling text Feb 1, 2024
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1
(60 ml)
HDPE bottle    15-0236-02 Labelling text Labelling text Feb 1, 2024
Labelling text Labelling text Feb 1, 2024
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1
(70 ml)
HDPE bottle 4.89 
KZSR*
15-0236-03 Labelling text Labelling text Feb 1, 2024
Labelling text Labelling text Feb 1, 2024
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N1
(100 ml)
HDPE bottle    15-0236-04 Labelling text Labelling text Feb 1, 2024
Labelling text Labelling text Feb 1, 2024
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. 15-0236
Date of authorisation Oct 5, 2015
Marketing authorisation holder, country KRKA, d.d., Novo mesto, Slovenia